Jorge joined Novo Ventures (US) Inc. in San Francisco, California in 2021.
Previously, Jorge was Executive Director of Corporate Development at Global Blood Therapeutics, where he led the sourcing, evaluation, and execution of partnerships and licensing transactions with large and small biotech partners. Prior to that, he worked in business development at Portola Pharmaceuticals and as a management consultant in the Life Sciences practice of L.E.K. Consulting.
Jorge earned his Ph.D. in Organic Chemistry from Yale University, where he designed, synthesized, and tested small molecule drugs that disrupt protein-protein interactions. He also conducted post-doctoral research at Boston University in the field of diversity-oriented synthesis.